- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Evaluation of Therapeutic Protocol Outcome in COVID-19 Inpatients in Baghdad | ||
| Iraqi Postgraduate Medical Journal | ||
| Article 9, Volume 23, Issue 2, April 2024, Pages 177-182 PDF (329.5 K) | ||
| Document Type: Research Paper | ||
| DOI: 10.52573/ipmj.2024.183749 | ||
| Authors | ||
| Roaa Abdul Hussein Swayah* 1; Saad Badai Nashtar2 | ||
| 1Al-Rusafa Primary Health Care Sector, Baghdad, Iraq | ||
| 2Al-Kindy College of Medicine Baghdad University, Baghdad, Iraq | ||
| Abstract | ||
| BACKGROUND: Severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which was declared as a global pandemic by the World Health Organization (WHO) on 11th March 2020. SARSCoV-2 was discovered in Wuhan City, China, in December 2019. The first patient with COVID-19 was reported in Iraq on 24 February 2020. At 15 July 2022 the Iraqi Ministry of Health reported 2,334,375 confirmed cases, a number of which 25,229 patients died, and 10,813,380 vaccinations were administered. OBJECTIVE: To find out how well a treatment plan works and what associated factors are involved among a group of COVID-19 patients. PATIENTS AND METHODS: A cross-sectional study in which a review of patients records was carried out at two designated centers for COVID 19 patients; Dar Al Salam hospital in Baghdad- Al Karkh side and Al Shefaa center in Al Kindy hospital, Baghdad- Al Rusafa side from first of August 2021 to 31 January 2022. RESULTS: A total of 304 COVID 19 patients were included in this study. There were 219 (72%) recovered patients and 85 (28%) deaths. Respiratory failure was the most common cause of death among patients 48 (15.8%), Followed by Renal failure then 27 (8.9%), and sepsis & septic shock 10 (3.3%). Recovery rate appeared to be significantly higher among patients without gastrointestinal tract (GIT) symptoms, with acceptable oxygen saturation, and of moderate severity, P=0.001, P<0.001, and P<0.001 respectively. CONCLUSION: Comorbidities including diabetes mellitus, hypertension, hypothyroidism, asthma, cerebrovascular diseases, Rheumatic disease, and obesity were without a statically significant association with\ the recovery but high mortality rate. Patients who were taking steroids were significantly more\ in recovered group. | ||
| Keywords | ||
| COVID_19; steroid; SARS_CoV-2; Comorbidities | ||
|
Supplementary Files
|
||
|
Statistics Article View: 311 PDF Download: 115 |
||
